Morphosys AG - ADR operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morphosys AG - ADR with three other
companies in this sector in the United States:
Aduro Biotech Inc
sales of $50.68 million
Reata Pharmaceuticals Inc
of which 100%
was Pharmaceutical), and
Luna Innovations Incorporated
During the year ended December of 2016, sales at
Morphosys AG - ADR were $54.90 million.
decrease of 53.1%
versus 2015, when the company's sales were $117.16 million.
Contributing to the drop in overall sales was the 99.0% decline
in Proprietary Development, from $66.11 million to $685,416.33 .
However, these declines were partially offset by the increase in sales of
Partnered Discovery (up 6.2% to $54.22 million)